A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus

Conditions:   Systemic Lupus Erythematosus;   Lupus Erythematosus Intervention:   Drug: Imvotamab Sponsor:   IGM Biosciences, Inc. Recruiting

Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials